Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrinology update 2006.

S Sethu K Reddy1

  • 1Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic Foundation, OH 44195, USA. sethu_reddy@merck.com

Cleveland Clinic Journal of Medicine
|November 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis Frequency and Associated Factors of Nonalcoholic Fatty Liver Disease Among United States Hospitalized Adults in Urban vs Rural Populations From 2007 to 2019: An Emerging Public Health Crisis.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025
Same author

Oral hyperpigmentation with weakness and salt-craving.

Cleveland Clinic journal of medicine·2022
Same author

Academic collaborations with industry: lessons for the future.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2020
Same author

Diagnosis of Diabetes Mellitus in Older Adults.

Clinics in geriatric medicine·2020
Same author

Improving Adherence in Type 2 Diabetes.

Clinics in geriatric medicine·2020
Same author

Artificial Intelligence and Digital Tools: Future of Diabetes Care.

Clinics in geriatric medicine·2020
Same journal

A 20-year-old woman with a 9-year history of shortness of breath.

Cleveland Clinic journal of medicine·2026
Same journal

A 70-year-old man with lower-extremity weakness and falls.

Cleveland Clinic journal of medicine·2026
Same journal

Treatment-refractory hypothyroidism: Don't just increase the dose.

Cleveland Clinic journal of medicine·2026
Same journal

In Reply: Beyond histologic improvement in MASH.

Cleveland Clinic journal of medicine·2026
Same journal

Comfort care: Creating a plan for hospitalized patients and their families.

Cleveland Clinic journal of medicine·2026
Same journal

Localized dead bone, a potential hint to an underlying condition.

Cleveland Clinic journal of medicine·2026
See all related articles

Strict glucose control in type 1 diabetes offers lasting benefits for complications. New treatments like inhaled insulin, pramlintide, and exenatide improve glycemic control and weight management.

Area of Science:

  • Endocrinology
  • Diabetes research
  • Metabolic disorders

Background:

  • Recent advancements in endocrinology offer new insights and treatments for diabetes and thyroid disorders.
  • The Epidemiology of Diabetes Interventions and Complications (EDIC) study provides long-term data on diabetes management.
  • Emerging research highlights novel roles for hormones and vitamins in metabolic health.

Purpose of the Study:

  • To summarize key recent developments in endocrinology.
  • To highlight the prolonged benefits of early intensive glucose control in type 1 diabetes.
  • To introduce new therapeutic options for diabetes management and discuss updated understanding of thyroid function and vitamin D.

Main Methods:

  • Review of findings from the Epidemiology of Diabetes Interventions and Complications study.

Related Experiment Videos

  • Discussion of newly available inhaled insulin preparations.
  • Overview of new injectable diabetes medications: pramlintide and exenatide.
  • Presentation of new evidence on thyroxine (T4) actions and thyrotropin (TSH) ranges.
  • Summary of research on vitamin D's role beyond calcium homeostasis.

    • Main Results:

    • Early strict glucose control in type 1 diabetes leads to sustained reduction in microvascular and cardiovascular complications.
    • Inhaled insulin is now available for mealtime glucose management.
    • Pramlintide and exenatide are effective adjuncts for patients struggling to reach hemoglobin A1c targets, aiding weight management.
    • Thyroxine (T4) exhibits direct cellular actions with potential implications for oncogenesis and angiogenesis.
    • A narrower therapeutic range for thyrotropin (TSH), potentially 0.4–2.5 mIU/L, is proposed.
    • Vitamin D plays a role in preventing type 1 diabetes.

    Conclusions:

    • Intensive glucose control in early type 1 diabetes yields long-term protective effects.
    • New pharmacologic options enhance diabetes treatment strategies.
    • Understanding of thyroid hormone action and vitamin D's broader health implications is evolving.